Font Size: a A A
Keyword [osteolytic]
Result: 1 - 20 | Page: 1 of 3
1. Differentiation Of Osteolytic Bone Tumors: Quantitative Assessment With CT Perfusion
2. Molecular Mechanisms Of Osteoclastgenesis And Local Modulation Of Osteoclast Differentiation And Activity In Osteolytic Diseases
3. Experimental Research Of Using Recombinant Human Bone Morphogenic Protein-2 Slow Release Formulation To Prevent Prothetic Aseptic Loosening
4. Diffusion-weighted MR Imaging Study On Lumbar Osteolytic Metastasis
5. CT Perfusion Volume Assessment Of Solitary Osteolytic Bone Lesions In Spine
6. 47 Cases Of Multiple Myeloma About Bony Disease Clinical Analysis Of Relevant Factors
7. Evaluation Of Percutaneous Kyphoplasty For Treating Osteolytic Tumor Of Vertebrae
8. The Effect Of PTHrP(1-34) On Bone Metastasis Of Mouse Breast Cancer Cells
9. Contribution Of Rankl-rank-opg In The Osteolytic Lesion Around Hydatidocystis Which Parasitize Spine Of Meriones Meridianus
10. Osteolytic Spiritual Point Injection Therapy Of Avascular Necrosis Of Clinical Studies
11. Osteolytic Capsule On The Morphology Of Steroid-induced Avascular Necrosis Of Bone Tissue
12. Clinical Research And The Effect Of Signal Transduction Mechanism On Treatment Of Metastasis Tumor By Yishengukangfang
13. The Research On The Mechanism Of Cyanidin Chloride Effect Osteolytic Disease
14. Mechanism Research Of MicroRNA 126-5p Regulating Proliferation And Osteolytic Microenvironment Of Giant Cell Tumor Of Bone
15. Molecular Mechanisms Of Gambogic Acid On Osteoclast Related Osteolytic Diseases
16. Percutaneous Vertebroplasty For Metastatic Lesions Of The Cervical Spine
17. Three-dimensional Finite Element Analysis And Mechanical Study On The Osteolytic Metastases Of Proximal Femoral
18. The Intervention Mechanism Of The Prescription For Yishengukang On Nude Mice With Osteolytic Bone Metastases
19. ER Stress-induced Apoptosis Of Osteoblasts Within The Osteolytic Osseous Tissues In Aseptic Loosening After Total Hip Replacement
20. Therapeutic Effects Of The Novel Subtype-selective Histone Deacetylase(HDAC)Inhibitor Chidamide On Myeloma-associated Bone Disease
  <<First  <Prev  Next>  Last>>  Jump to